Hypoxia induces dichotomous and reversible attenuation of T cell responses through reactive oxygen species-dependent phenotype redistribution and delay in lymphoblast proliferation

References

• Carreau A, Hafny-Rahbi BE, Matejuk A, et al. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011;15(6):1239–1253.
   PubMed Web of Science ®Google Scholar
• Zenewicz LA. Oxygen levels and immunological studies. Front Immunol. 2017;8:324–324.
   PubMedGoogle Scholar
• Laser H. Tissue metabolism under the influence of low oxygen tension. Biochem J. 1937;31(9):1671–1676.
   PubMedGoogle Scholar
• Buck ’D, O'Sullivan D, Klein Geltink RI, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166(1):63–76.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Poffenberger MC, Chang CH, et al. Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013;342(6155):1242454.
   PubMedGoogle Scholar
• Cho SH, Raybuck AL, Blagih J, et al. Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity. Proc Natl Acad Sci USA. 2019;116(18):8975–8984.
   PubMedGoogle Scholar
• Haddad H, Windgassen D, Ramsborg CG, et al. Molecular understanding of oxygen-tension and patient-variability effects on ex vivo expanded T cells. Biotechnol Bioeng. 2004;87(4):437–450.
   PubMedGoogle Scholar
• Chi JT, Wang Z, Nuyten DS, et al. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 2006;3(3):E47. and others
   PubMed Web of Science ®Google Scholar
• Krieger JA, Landsiedel JC, Lawrence DA. Differential in vitro effects of physiological and atmospheric oxygen tension on normal human peripheral blood mononuclear cell proliferation, cytokine and immunoglobulin production. Int J Immunopharmacol. 1996;18(10):545–552.
   PubMedGoogle Scholar
• Caldwell CC, Kojima H, Lukashev D, et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol. 2001;167(11):6140–6149.
   PubMed Web of Science ®Google Scholar
• Gropper Y, Feferman T, Shalit T, et al. Culturing CTLs under hypoxic conditions enhances their cytolysis and improves their anti-tumor function. Cell Rep. 2017;20(11):2547–2555.
   PubMedGoogle Scholar
• Derevianko A, D'Amico R, Simms H. Polymorphonuclear leucocyte (PMN)-derived inflammatory cytokines–regulation by oxygen tension and extracellular matrix. Clin Exp Immunol. 1996;106(3):560–567.
   PubMedGoogle Scholar
• Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, et al. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45(8):2263–2275.
   PubMedGoogle Scholar
• Atkuri KR, Herzenberg LA, Herzenberg LA. Culturing at atmospheric oxygen levels impacts lymphocyte function. Proc Natl Acad Sci USA. 2005;102(10):3756–3759.
   PubMedGoogle Scholar
• Atkuri KR, Herzenberg LA, Niemi A-K, et al. Importance of culturing primary lymphocytes at physiological oxygen levels. Proc Natl Acad Sci USA. 2007;104(11):4547–4552.
   PubMedGoogle Scholar
• Gaber T, Tran CL, Schellmann S, et al. Pathophysiological hypoxia affects the redox state and IL-2 signalling of human CD4+ T cells and concomitantly impairs survival and proliferation. Eur J Immunol. 2013;43(6):1588–1597.
   PubMedGoogle Scholar
• Jayaprakash P, Ai M, Liu A, et al. Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. J Clin Invest. 2018;128(11):5137–5149.
   PubMed Web of Science ®Google Scholar
• Roman J, Rangasamy T, Guo J, et al. T-cell activation under hypoxic conditions enhances IFN-gamma secretion. Am J Respir Cell Mol Biol. 2010;42(1):123–128.
   PubMedGoogle Scholar
• Doedens AL, Phan AT, Stradner MH, et al. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol. 2013;14(11):1173–1182.
   PubMed Web of Science ®Google Scholar
• Xu Y, Chaudhury A, Zhang M, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126(7):2678–2688.
   PubMed Web of Science ®Google Scholar
• Vallejo AN, Yang H, Klimiuk PA, et al. Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J Immunol. 2003;171(4):1732–1740.
   PubMedGoogle Scholar
• Wakim LM, Gebhardt T, Heath WR, et al. Cutting edge: local recall responses by memory T cells newly recruited to peripheral nonlymphoid tissues. J Immunol. 2008;181(9):5837–5841.
   PubMedGoogle Scholar
• Marten NW, Stohlman SA, Zhou J, et al. Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection. J Virol. 2003;77(4):2775–2778.
   PubMed Web of Science ®Google Scholar
• McClain MT, Park LP, Nicholson B, et al. Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. J Clin Virol. 2013;58(4):689–695.
   PubMed Web of Science ®Google Scholar
• Mathew D, Giles JR, Baxter AE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):eabc8511.
   PubMedGoogle Scholar
• Combes AJ, Courau T, Kuhn NF, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591(7848):124–130.
   PubMedGoogle Scholar
• Kuri-Cervantes L, Pampena MB, Meng W, et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. 2020;5(49):eabd7114.
   PubMedGoogle Scholar
• Checker R, Patwardhan RS, Sharma D, et al. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB. Free Radic Biol Med. 2012;53(7):1421–1430.
   PubMed Web of Science ®Google Scholar
• Hanuma Kumar GEN, Kumar SS, Balaji M, et al. Pterocarpus santalinus L. extract mitigates gamma radiation-inflicted derangements in BALB/c mice by Nrf2 upregulation. Biomed Pharmacother. 2021;141:111801.
   PubMedGoogle Scholar
• Patwardhan RS, Sharma D, Thoh M, et al. Baicalein exhibits anti-inflammatory effects via inhibition of NF-κB transactivation. Biochem Pharmacol. 2016;108:75–89.
   PubMedGoogle Scholar
• Makino Y, Nakamura H, Ikeda E, et al. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol. 2003;171(12):6534–6540.
   PubMedGoogle Scholar
• Hochgerner M, Sturm EM, Schnoegl D, et al. Low oxygen levels decrease adaptive immune responses and ameliorate experimental asthma in mice. Allergy. 2022;77(3):870–882.
   PubMedGoogle Scholar
• Robbins JR, Lee SM, Filipovich AH, et al. Hypoxia modulates early events in T cell receptor-mediated activation in human T lymphocytes via Kv1.3 channels. J Physiol. 2005;564(Pt):1):131–43.
   Google Scholar
• Conforti L, Petrovic M, Mohammad D, et al. Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: a possible role in T cell proliferation. J Immunol. 2003;170(2):695–702.
   PubMedGoogle Scholar
• Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem. 2000;275(33):25130–25138.
   PubMed Web of Science ®Google Scholar
• Bell EL, Klimova TA, Eisenbart J, et al. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol. 2007;177(6):1029–1036.
   PubMed Web of Science ®Google Scholar
• Brunelle JK, Bell EL, Quesada NM, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005;1(6):409–414.
   PubMed Web of Science ®Google Scholar
• Klimova T, Chandel NS. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008;15(4):660–666.
   PubMed Web of Science ®Google Scholar
• Havens CG, Ho A, Yoshioka N, et al. Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Mol Cell Biol. 2006;26(12):4701–4711.
   PubMed Web of Science ®Google Scholar
• Patwardhan RS, Singh B, Pal D, et al. Redox regulation of regulatory T-cell differentiation and functions. Free Radical Research. 2020;54(11-12):947–960.
   PubMedGoogle Scholar
• Previte DM, O’Connor EC, Novak EA, et al. Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation. PloS One. 2017;12(4):e0175549.
   PubMedGoogle Scholar
• Sena LA, Li S, Jairaman A, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 2013;38(2):225–236.
   PubMed Web of Science ®Google Scholar
• Mak TW, Grusdat M, Duncan GS, et al. Glutathione primes T cell metabolism for inflammation. Immunity. 2017;46(4):675–689.
   PubMed Web of Science ®Google Scholar
• Wulff H, Calabresi PA, Allie R, et al. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest. 2003;111(11):1703–1713.
   PubMed Web of Science ®Google Scholar
• Sim JH, Kim KS, Park H, et al. Differentially expressed potassium channels are associated with function of human effector memory CD8+ T cells. Front Immunol. 2017;8(859). https://doi.org/10.3389/fimmu.2017.00859
   Google Scholar
• Hou P, Zhang R, Liu Y, et al. Physiological role of Kv1.3 channel in T lymphocyte cell investigated quantitatively by kinetic modeling. PloS One. 2014;9(3):e89975.
   PubMedGoogle Scholar
• Macallan DC, Busch R, Asquith B. Current estimates of T cell kinetics in humans. Curr Opin Syst Biol. 2019;18:77–86.
   PubMedGoogle Scholar